Vitamin B12 trial aims to stop Chemo's painful side effect

NCT ID NCT07423390

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether taking mecobalamin (a form of vitamin B12) can prevent or reduce nerve damage caused by taxane chemotherapy. About 326 adults with various solid tumors will take mecobalamin tablets or receive no preventive treatment during their chemo. The goal is to see if fewer people develop numbness, tingling, or pain in their hands and feet.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
mecobalamin (a form of vitamin B12)
What this could lead to
If it works, this could provide a simple, low-cost way to prevent painful nerve damage during chemotherapy.
What could go wrong
This is a single-center trial, and the benefit may be modest or not confirmed. Mecobalamin is generally safe but may not prevent all nerve symptoms.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital)

    NOT_YET_RECRUITING

    Jinan, Shandong, China

  • Affiliated Hospital of Qinghai University

    NOT_YET_RECRUITING

    Xining, Qinghai, China

  • Beijing Chaoyang Sanhuan Cancer Hospital

    RECRUITING

    Beijing, China

  • Qinghai Red Cross Hospital

    RECRUITING

    Xining, Qinghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.